147 related articles for article (PubMed ID: 24145675)
1. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.
Däbritz J; Bonkowski E; Chalk C; Trapnell BC; Langhorst J; Denson LA; Foell D
Am J Gastroenterol; 2013 Dec; 108(12):1901-10. PubMed ID: 24145675
[TBL] [Abstract][Full Text] [Related]
2. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.
Wright SS; Trauernicht A; Bonkowski E; McCall CA; Maier EA; Bezold R; Lake K; Chalk C; Trapnell BC; Kim MO; Kugathasan S; Denson LA
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):767-772. PubMed ID: 29216019
[TBL] [Abstract][Full Text] [Related]
3. Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12.
Däbritz J; Langhorst J; Lügering A; Heidemann J; Mohr M; Wittkowski H; Krummenerl T; Foell D
Inflamm Bowel Dis; 2013 May; 19(6):1130-8. PubMed ID: 23377171
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
[TBL] [Abstract][Full Text] [Related]
5. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
Nylund CM; D'Mello S; Kim MO; Bonkowski E; Däbritz J; Foell D; Meddings J; Trapnell BC; Denson LA
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):542-8. PubMed ID: 21502824
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.
Bonneau J; Dumestre-Perard C; Rinaudo-Gaujous M; Genin C; Sparrow M; Roblin X; Paul S
Autoimmun Rev; 2015 Mar; 14(3):231-45. PubMed ID: 25462578
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
Dykes DM; Towbin AJ; Bonkowski E; Chalk C; Bezold R; Lake K; Kim MO; Heubi JE; Trapnell BC; Podberesky DJ; Denson LA
Inflamm Bowel Dis; 2013 Sep; 19(10):2146-54. PubMed ID: 23893081
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
11. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.
Jurickova I; Collins MH; Chalk C; Seese A; Bezold R; Lake K; von Allmen D; Frischer JS; Falcone RA; Trapnell BC; Denson LA
Clin Exp Immunol; 2013 Jun; 172(3):455-65. PubMed ID: 23600834
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou D; Valencia CA; Dodd A; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
Inflamm Bowel Dis; 2019 Feb; 25(3):547-560. PubMed ID: 30124884
[TBL] [Abstract][Full Text] [Related]
13. Increased secretion of granulocyte-macrophage colony-stimulating factor in mucosal lesions of inflammatory bowel disease.
Noguchi M; Hiwatashi N; Liu ZX; Toyota T
Digestion; 2001; 63 Suppl 1():32-6. PubMed ID: 11173907
[TBL] [Abstract][Full Text] [Related]
14. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
15. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
Heinzelman P; Carlson SJ; Cox GN
Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
[TBL] [Abstract][Full Text] [Related]
16. High Levels of Anti-GM-CSF Antibodies in Deep Infiltrating Endometriosis.
Toullec L; Batteux F; Santulli P; Chouzenoux S; Jeljeli M; Belmondo T; Hue S; Chapron C
Reprod Sci; 2020 Jan; 27(1):211-217. PubMed ID: 32046390
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
18. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
[TBL] [Abstract][Full Text] [Related]
19. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.
Ina K; Kusugami K; Hosokawa T; Imada A; Shimizu T; Yamaguchi T; Ohsuga M; Kyokane K; Sakai T; Nishio Y; Yokoyama Y; Ando T
J Gastroenterol Hepatol; 1999 Jan; 14(1):46-53. PubMed ID: 10029277
[TBL] [Abstract][Full Text] [Related]
20. Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
Molander P; Färkkilä M; Ristimäki A; Salminen K; Kemppainen H; Blomster T; Koskela R; Jussila A; Rautiainen H; Nissinen M; Haapamäki J; Arkkila P; Nieminen U; Kuisma J; Punkkinen J; Kolho KL; Mustonen H; Sipponen T
J Crohns Colitis; 2015 Jan; 9(1):33-40. PubMed ID: 25052347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
